Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

Background. Life-threatening Streptococcus pneumoniae infections often occur after hematopoietic stem cell transplant (HSCT); vaccination is important for prevention. Methods. In an open-label study, patients (n = 251) 3–6 months after allogeneic HSCT received 3 doses of 13-valent pneumococcal conju...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordonnier, Catherine, Ljungman, Per, Juergens, Christine, Maertens, Johan, Selleslag, Dominik, Sundaraiyer, Vani, Giardina, Peter C., Clarke, Keri, Gruber, William C., Scott, Daniel A., Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503811/
https://www.ncbi.nlm.nih.gov/pubmed/25870329
http://dx.doi.org/10.1093/cid/civ287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503811/
https://www.ncbi.nlm.nih.gov/pubmed/25870329
http://dx.doi.org/10.1093/cid/civ287

Ejemplares similares